Updates in Surgery-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2238087, encodeId=35f7223808e27, content=胆道外科方向论著性文章，大修后接收，前后经历8个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff3a6146368, createdName=ms2000000943540373, createdTime=Wed Nov 20 23:33:47 CST 2024, time=2024-11-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161316, encodeId=30722161316ed, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：cell therapy 经验分享：好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c569003305, createdName=ms2000000073478817, createdTime=Sat Oct 07 11:37:02 CST 2023, time=2023-10-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147727, encodeId=7cf7214e7276f, content=with editor 2个月了，有他们有没有送外审环节啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3638765206, createdName=ms4000000138211847, createdTime=Wed Jul 12 21:41:58 CST 2023, time=2023-07-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2157733, encodeId=776f215e7335d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f035593507, createdName=ms1000000858609486, createdTime=Thu Sep 14 20:57:06 CST 2023, time=2023-09-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2152322, encodeId=432a21523228b, content=偏重的研究方向：炎症性肠病 经验分享：under review 快1个月了不知道有没有送出去外审额。。。。等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Fri Aug 11 20:48:03 CST 2023, time=2023-08-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2125531, encodeId=54e52125531e5, content=请问一下各位大佬，with editor已经半个月了，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4c8367238, createdName=ms9000001891654753, createdTime=Wed Apr 12 22:17:20 CST 2023, time=2023-04-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2147332, encodeId=1480214e33212, content=各位大佬，投稿的时候没有是否OA的选项，请问是在哪选择OA呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690e8333525, createdName=ms5000000761268362, createdTime=Mon Jul 10 18:51:59 CST 2023, time=2023-07-10, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2129665, encodeId=f6f7212966562, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：投稿一个月了还是with editor，打算撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Tue May 02 08:01:20 CST 2023, time=2023-05-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1108527, encodeId=0c7f110852ef5, content=为什么要从MeSH里筛选关键词？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1108528, encodeId=6bc4110852859, content=关键词筛选有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2024-11-20 ms2000000943540373 来自四川省

胆道外科方向论著性文章，大修后接收，前后经历8个月

21 0

[GetPortalCommentsPageByObjectIdResponse(id=2238087, encodeId=35f7223808e27, content=胆道外科方向论著性文章，大修后接收，前后经历8个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff3a6146368, createdName=ms2000000943540373, createdTime=Wed Nov 20 23:33:47 CST 2024, time=2024-11-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161316, encodeId=30722161316ed, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：cell therapy 经验分享：好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c569003305, createdName=ms2000000073478817, createdTime=Sat Oct 07 11:37:02 CST 2023, time=2023-10-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147727, encodeId=7cf7214e7276f, content=with editor 2个月了，有他们有没有送外审环节啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3638765206, createdName=ms4000000138211847, createdTime=Wed Jul 12 21:41:58 CST 2023, time=2023-07-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2157733, encodeId=776f215e7335d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f035593507, createdName=ms1000000858609486, createdTime=Thu Sep 14 20:57:06 CST 2023, time=2023-09-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2152322, encodeId=432a21523228b, content=偏重的研究方向：炎症性肠病 经验分享：under review 快1个月了不知道有没有送出去外审额。。。。等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Fri Aug 11 20:48:03 CST 2023, time=2023-08-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2125531, encodeId=54e52125531e5, content=请问一下各位大佬，with editor已经半个月了，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4c8367238, createdName=ms9000001891654753, createdTime=Wed Apr 12 22:17:20 CST 2023, time=2023-04-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2147332, encodeId=1480214e33212, content=各位大佬，投稿的时候没有是否OA的选项，请问是在哪选择OA呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690e8333525, createdName=ms5000000761268362, createdTime=Mon Jul 10 18:51:59 CST 2023, time=2023-07-10, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2129665, encodeId=f6f7212966562, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：投稿一个月了还是with editor，打算撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Tue May 02 08:01:20 CST 2023, time=2023-05-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1108527, encodeId=0c7f110852ef5, content=为什么要从MeSH里筛选关键词？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1108528, encodeId=6bc4110852859, content=关键词筛选有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2023-10-07 ms2000000073478817 来自广东省

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：cell therapy
经验分享：好的

92 0

[GetPortalCommentsPageByObjectIdResponse(id=2238087, encodeId=35f7223808e27, content=胆道外科方向论著性文章，大修后接收，前后经历8个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff3a6146368, createdName=ms2000000943540373, createdTime=Wed Nov 20 23:33:47 CST 2024, time=2024-11-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161316, encodeId=30722161316ed, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：cell therapy 经验分享：好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c569003305, createdName=ms2000000073478817, createdTime=Sat Oct 07 11:37:02 CST 2023, time=2023-10-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147727, encodeId=7cf7214e7276f, content=with editor 2个月了，有他们有没有送外审环节啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3638765206, createdName=ms4000000138211847, createdTime=Wed Jul 12 21:41:58 CST 2023, time=2023-07-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2157733, encodeId=776f215e7335d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f035593507, createdName=ms1000000858609486, createdTime=Thu Sep 14 20:57:06 CST 2023, time=2023-09-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2152322, encodeId=432a21523228b, content=偏重的研究方向：炎症性肠病 经验分享：under review 快1个月了不知道有没有送出去外审额。。。。等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Fri Aug 11 20:48:03 CST 2023, time=2023-08-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2125531, encodeId=54e52125531e5, content=请问一下各位大佬，with editor已经半个月了，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4c8367238, createdName=ms9000001891654753, createdTime=Wed Apr 12 22:17:20 CST 2023, time=2023-04-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2147332, encodeId=1480214e33212, content=各位大佬，投稿的时候没有是否OA的选项，请问是在哪选择OA呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690e8333525, createdName=ms5000000761268362, createdTime=Mon Jul 10 18:51:59 CST 2023, time=2023-07-10, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2129665, encodeId=f6f7212966562, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：投稿一个月了还是with editor，打算撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Tue May 02 08:01:20 CST 2023, time=2023-05-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1108527, encodeId=0c7f110852ef5, content=为什么要从MeSH里筛选关键词？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1108528, encodeId=6bc4110852859, content=关键词筛选有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2023-07-12 ms4000000138211847 来自重庆

with editor 2个月了，有他们有没有送外审环节啊？

124 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2238087, encodeId=35f7223808e27, content=胆道外科方向论著性文章，大修后接收，前后经历8个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff3a6146368, createdName=ms2000000943540373, createdTime=Wed Nov 20 23:33:47 CST 2024, time=2024-11-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161316, encodeId=30722161316ed, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：cell therapy 经验分享：好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c569003305, createdName=ms2000000073478817, createdTime=Sat Oct 07 11:37:02 CST 2023, time=2023-10-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147727, encodeId=7cf7214e7276f, content=with editor 2个月了，有他们有没有送外审环节啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3638765206, createdName=ms4000000138211847, createdTime=Wed Jul 12 21:41:58 CST 2023, time=2023-07-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2157733, encodeId=776f215e7335d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f035593507, createdName=ms1000000858609486, createdTime=Thu Sep 14 20:57:06 CST 2023, time=2023-09-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2152322, encodeId=432a21523228b, content=偏重的研究方向：炎症性肠病 经验分享：under review 快1个月了不知道有没有送出去外审额。。。。等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Fri Aug 11 20:48:03 CST 2023, time=2023-08-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2125531, encodeId=54e52125531e5, content=请问一下各位大佬，with editor已经半个月了，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4c8367238, createdName=ms9000001891654753, createdTime=Wed Apr 12 22:17:20 CST 2023, time=2023-04-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2147332, encodeId=1480214e33212, content=各位大佬，投稿的时候没有是否OA的选项，请问是在哪选择OA呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690e8333525, createdName=ms5000000761268362, createdTime=Mon Jul 10 18:51:59 CST 2023, time=2023-07-10, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2129665, encodeId=f6f7212966562, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：投稿一个月了还是with editor，打算撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Tue May 02 08:01:20 CST 2023, time=2023-05-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1108527, encodeId=0c7f110852ef5, content=为什么要从MeSH里筛选关键词？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1108528, encodeId=6bc4110852859, content=关键词筛选有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2023-09-14 ms1000000858609486 来自广东省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：外科
经验分享：很不错

100 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2238087, encodeId=35f7223808e27, content=胆道外科方向论著性文章，大修后接收，前后经历8个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff3a6146368, createdName=ms2000000943540373, createdTime=Wed Nov 20 23:33:47 CST 2024, time=2024-11-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161316, encodeId=30722161316ed, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：cell therapy 经验分享：好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c569003305, createdName=ms2000000073478817, createdTime=Sat Oct 07 11:37:02 CST 2023, time=2023-10-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147727, encodeId=7cf7214e7276f, content=with editor 2个月了，有他们有没有送外审环节啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3638765206, createdName=ms4000000138211847, createdTime=Wed Jul 12 21:41:58 CST 2023, time=2023-07-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2157733, encodeId=776f215e7335d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f035593507, createdName=ms1000000858609486, createdTime=Thu Sep 14 20:57:06 CST 2023, time=2023-09-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2152322, encodeId=432a21523228b, content=偏重的研究方向：炎症性肠病 经验分享：under review 快1个月了不知道有没有送出去外审额。。。。等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Fri Aug 11 20:48:03 CST 2023, time=2023-08-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2125531, encodeId=54e52125531e5, content=请问一下各位大佬，with editor已经半个月了，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4c8367238, createdName=ms9000001891654753, createdTime=Wed Apr 12 22:17:20 CST 2023, time=2023-04-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2147332, encodeId=1480214e33212, content=各位大佬，投稿的时候没有是否OA的选项，请问是在哪选择OA呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690e8333525, createdName=ms5000000761268362, createdTime=Mon Jul 10 18:51:59 CST 2023, time=2023-07-10, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2129665, encodeId=f6f7212966562, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：投稿一个月了还是with editor，打算撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Tue May 02 08:01:20 CST 2023, time=2023-05-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1108527, encodeId=0c7f110852ef5, content=为什么要从MeSH里筛选关键词？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1108528, encodeId=6bc4110852859, content=关键词筛选有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2023-08-11 超超不吵吵来自湖南省

偏重的研究方向：炎症性肠病
经验分享：under review 快1个月了不知道有没有送出去外审额。。。。等待中

123 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2238087, encodeId=35f7223808e27, content=胆道外科方向论著性文章，大修后接收，前后经历8个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff3a6146368, createdName=ms2000000943540373, createdTime=Wed Nov 20 23:33:47 CST 2024, time=2024-11-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161316, encodeId=30722161316ed, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：cell therapy 经验分享：好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c569003305, createdName=ms2000000073478817, createdTime=Sat Oct 07 11:37:02 CST 2023, time=2023-10-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147727, encodeId=7cf7214e7276f, content=with editor 2个月了，有他们有没有送外审环节啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3638765206, createdName=ms4000000138211847, createdTime=Wed Jul 12 21:41:58 CST 2023, time=2023-07-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2157733, encodeId=776f215e7335d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f035593507, createdName=ms1000000858609486, createdTime=Thu Sep 14 20:57:06 CST 2023, time=2023-09-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2152322, encodeId=432a21523228b, content=偏重的研究方向：炎症性肠病 经验分享：under review 快1个月了不知道有没有送出去外审额。。。。等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Fri Aug 11 20:48:03 CST 2023, time=2023-08-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2125531, encodeId=54e52125531e5, content=请问一下各位大佬，with editor已经半个月了，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4c8367238, createdName=ms9000001891654753, createdTime=Wed Apr 12 22:17:20 CST 2023, time=2023-04-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2147332, encodeId=1480214e33212, content=各位大佬，投稿的时候没有是否OA的选项，请问是在哪选择OA呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690e8333525, createdName=ms5000000761268362, createdTime=Mon Jul 10 18:51:59 CST 2023, time=2023-07-10, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2129665, encodeId=f6f7212966562, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：投稿一个月了还是with editor，打算撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Tue May 02 08:01:20 CST 2023, time=2023-05-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1108527, encodeId=0c7f110852ef5, content=为什么要从MeSH里筛选关键词？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1108528, encodeId=6bc4110852859, content=关键词筛选有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2023-04-12 ms9000001891654753 来自安徽省

请问一下各位大佬，with editor已经半个月了，什么情况？

103 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2238087, encodeId=35f7223808e27, content=胆道外科方向论著性文章，大修后接收，前后经历8个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff3a6146368, createdName=ms2000000943540373, createdTime=Wed Nov 20 23:33:47 CST 2024, time=2024-11-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161316, encodeId=30722161316ed, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：cell therapy 经验分享：好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c569003305, createdName=ms2000000073478817, createdTime=Sat Oct 07 11:37:02 CST 2023, time=2023-10-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147727, encodeId=7cf7214e7276f, content=with editor 2个月了，有他们有没有送外审环节啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3638765206, createdName=ms4000000138211847, createdTime=Wed Jul 12 21:41:58 CST 2023, time=2023-07-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2157733, encodeId=776f215e7335d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f035593507, createdName=ms1000000858609486, createdTime=Thu Sep 14 20:57:06 CST 2023, time=2023-09-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2152322, encodeId=432a21523228b, content=偏重的研究方向：炎症性肠病 经验分享：under review 快1个月了不知道有没有送出去外审额。。。。等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Fri Aug 11 20:48:03 CST 2023, time=2023-08-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2125531, encodeId=54e52125531e5, content=请问一下各位大佬，with editor已经半个月了，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4c8367238, createdName=ms9000001891654753, createdTime=Wed Apr 12 22:17:20 CST 2023, time=2023-04-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2147332, encodeId=1480214e33212, content=各位大佬，投稿的时候没有是否OA的选项，请问是在哪选择OA呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690e8333525, createdName=ms5000000761268362, createdTime=Mon Jul 10 18:51:59 CST 2023, time=2023-07-10, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2129665, encodeId=f6f7212966562, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：投稿一个月了还是with editor，打算撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Tue May 02 08:01:20 CST 2023, time=2023-05-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1108527, encodeId=0c7f110852ef5, content=为什么要从MeSH里筛选关键词？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1108528, encodeId=6bc4110852859, content=关键词筛选有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2023-07-10 ms5000000761268362 来自甘肃省

各位大佬，投稿的时候没有是否OA的选项，请问是在哪选择OA呀

117 0

[GetPortalCommentsPageByObjectIdResponse(id=2238087, encodeId=35f7223808e27, content=胆道外科方向论著性文章，大修后接收，前后经历8个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff3a6146368, createdName=ms2000000943540373, createdTime=Wed Nov 20 23:33:47 CST 2024, time=2024-11-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161316, encodeId=30722161316ed, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：cell therapy 经验分享：好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c569003305, createdName=ms2000000073478817, createdTime=Sat Oct 07 11:37:02 CST 2023, time=2023-10-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147727, encodeId=7cf7214e7276f, content=with editor 2个月了，有他们有没有送外审环节啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3638765206, createdName=ms4000000138211847, createdTime=Wed Jul 12 21:41:58 CST 2023, time=2023-07-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2157733, encodeId=776f215e7335d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f035593507, createdName=ms1000000858609486, createdTime=Thu Sep 14 20:57:06 CST 2023, time=2023-09-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2152322, encodeId=432a21523228b, content=偏重的研究方向：炎症性肠病 经验分享：under review 快1个月了不知道有没有送出去外审额。。。。等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Fri Aug 11 20:48:03 CST 2023, time=2023-08-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2125531, encodeId=54e52125531e5, content=请问一下各位大佬，with editor已经半个月了，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4c8367238, createdName=ms9000001891654753, createdTime=Wed Apr 12 22:17:20 CST 2023, time=2023-04-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2147332, encodeId=1480214e33212, content=各位大佬，投稿的时候没有是否OA的选项，请问是在哪选择OA呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690e8333525, createdName=ms5000000761268362, createdTime=Mon Jul 10 18:51:59 CST 2023, time=2023-07-10, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2129665, encodeId=f6f7212966562, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：投稿一个月了还是with editor，打算撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Tue May 02 08:01:20 CST 2023, time=2023-05-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1108527, encodeId=0c7f110852ef5, content=为什么要从MeSH里筛选关键词？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1108528, encodeId=6bc4110852859, content=关键词筛选有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2023-05-02 左手摸机来自浙江省

审稿速度:6.0 | 投稿命中率:50.0
经验分享：投稿一个月了还是with editor，打算撤稿了

116 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2238087, encodeId=35f7223808e27, content=胆道外科方向论著性文章，大修后接收，前后经历8个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff3a6146368, createdName=ms2000000943540373, createdTime=Wed Nov 20 23:33:47 CST 2024, time=2024-11-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161316, encodeId=30722161316ed, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：cell therapy 经验分享：好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c569003305, createdName=ms2000000073478817, createdTime=Sat Oct 07 11:37:02 CST 2023, time=2023-10-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147727, encodeId=7cf7214e7276f, content=with editor 2个月了，有他们有没有送外审环节啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3638765206, createdName=ms4000000138211847, createdTime=Wed Jul 12 21:41:58 CST 2023, time=2023-07-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2157733, encodeId=776f215e7335d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f035593507, createdName=ms1000000858609486, createdTime=Thu Sep 14 20:57:06 CST 2023, time=2023-09-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2152322, encodeId=432a21523228b, content=偏重的研究方向：炎症性肠病 经验分享：under review 快1个月了不知道有没有送出去外审额。。。。等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Fri Aug 11 20:48:03 CST 2023, time=2023-08-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2125531, encodeId=54e52125531e5, content=请问一下各位大佬，with editor已经半个月了，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4c8367238, createdName=ms9000001891654753, createdTime=Wed Apr 12 22:17:20 CST 2023, time=2023-04-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2147332, encodeId=1480214e33212, content=各位大佬，投稿的时候没有是否OA的选项，请问是在哪选择OA呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690e8333525, createdName=ms5000000761268362, createdTime=Mon Jul 10 18:51:59 CST 2023, time=2023-07-10, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2129665, encodeId=f6f7212966562, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：投稿一个月了还是with editor，打算撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Tue May 02 08:01:20 CST 2023, time=2023-05-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1108527, encodeId=0c7f110852ef5, content=为什么要从MeSH里筛选关键词？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1108528, encodeId=6bc4110852859, content=关键词筛选有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-12-27 小动量

为什么要从MeSH里筛选关键词？

128 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2238087, encodeId=35f7223808e27, content=胆道外科方向论著性文章，大修后接收，前后经历8个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff3a6146368, createdName=ms2000000943540373, createdTime=Wed Nov 20 23:33:47 CST 2024, time=2024-11-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161316, encodeId=30722161316ed, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：cell therapy 经验分享：好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c569003305, createdName=ms2000000073478817, createdTime=Sat Oct 07 11:37:02 CST 2023, time=2023-10-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147727, encodeId=7cf7214e7276f, content=with editor 2个月了，有他们有没有送外审环节啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3638765206, createdName=ms4000000138211847, createdTime=Wed Jul 12 21:41:58 CST 2023, time=2023-07-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2157733, encodeId=776f215e7335d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f035593507, createdName=ms1000000858609486, createdTime=Thu Sep 14 20:57:06 CST 2023, time=2023-09-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2152322, encodeId=432a21523228b, content=偏重的研究方向：炎症性肠病 经验分享：under review 快1个月了不知道有没有送出去外审额。。。。等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Fri Aug 11 20:48:03 CST 2023, time=2023-08-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2125531, encodeId=54e52125531e5, content=请问一下各位大佬，with editor已经半个月了，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4c8367238, createdName=ms9000001891654753, createdTime=Wed Apr 12 22:17:20 CST 2023, time=2023-04-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2147332, encodeId=1480214e33212, content=各位大佬，投稿的时候没有是否OA的选项，请问是在哪选择OA呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690e8333525, createdName=ms5000000761268362, createdTime=Mon Jul 10 18:51:59 CST 2023, time=2023-07-10, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2129665, encodeId=f6f7212966562, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：投稿一个月了还是with editor，打算撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Tue May 02 08:01:20 CST 2023, time=2023-05-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1108527, encodeId=0c7f110852ef5, content=为什么要从MeSH里筛选关键词？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1108528, encodeId=6bc4110852859, content=关键词筛选有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-12-27 衣谷

关键词筛选有什么要求？

126 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务